{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:36:21Z","timestamp":1769560581564,"version":"3.49.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.drudis.2008.10.005","type":"journal-article","created":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T05:55:20Z","timestamp":1228629320000},"page":"168-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Perispinal etanercept for neuroinflammatory disorders"],"prefix":"10.1016","volume":"14","author":[{"given":"Edward","family":"Tobinick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2008.10.005_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ddmec.2004.11.018","article-title":"Mechanisms of neuropathic pain: the role of cytokines","volume":"1","author":"Sommer","year":"2004","journal-title":"Drug Discov. Today: Dis. Mech."},{"key":"10.1016\/j.drudis.2008.10.005_bib2","first-page":"278","article-title":"Proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches","volume":"82","author":"Van Eldik","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.drudis.2008.10.005_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/156720507781788873","article-title":"TNF-alpha Inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets","volume":"4","author":"Tweedie","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.drudis.2008.10.005_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cytogfr.2007.04.002","article-title":"How TNF was recognized as a key mechanism of disease","volume":"18","author":"Clark","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.drudis.2008.10.005_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molmed.2006.12.005","article-title":"The tripartite synapse: roles for gliotransmission in health and disease","volume":"13","author":"Halassa","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.drudis.2008.10.005_bib6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn1722","article-title":"Astrocytes, from brain glue to communication elements: the revolution continues","volume":"6","author":"Volterra","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2008.10.005_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.tins.2007.06.007","article-title":"Glia: they make your memories stick!","volume":"30","author":"Bains","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.drudis.2008.10.005_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1113\/expphysiol.2005.030734","article-title":"Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system","volume":"90","author":"Pickering","year":"2005","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.drudis.2008.10.005_bib9","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1111\/j.1460-9568.2005.04457.x","article-title":"Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor","volume":"22","author":"Wang","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"Pt 5","key":"10.1016\/j.drudis.2008.10.005_bib10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1042\/BST0351219","article-title":"Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction","volume":"35","author":"Rowan","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drudis.2008.10.005_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1359-6446(05)03637-8","article-title":"The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets","volume":"11","author":"Myers","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2008.10.005_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1529-8027.2001.01010.x","article-title":"Etanercept reduces hyperalgesia in experimental painful neuropathy","volume":"6","author":"Sommer","year":"2001","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.drudis.2008.10.005_bib13","first-page":"1725","article-title":"Etanercept Immunex","volume":"2","author":"Pugsley","year":"2001","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.drudis.2008.10.005_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2008.10.005_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuroscience.2004.12.035","article-title":"Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice","volume":"132","author":"Wacnik","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.drudis.2008.10.005_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000096887","article-title":"Permeability of the blood\u2013brain barrier to soluble cytokine receptors","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.drudis.2008.10.005_bib17","first-page":"53","article-title":"The cerebrospinal venous system: anatomy, physiology, and clinical implications","volume":"8","author":"Tobinick","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.drudis.2008.10.005_bib18","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1371\/journal.pmed.0030511","article-title":"Spinal delivery of p38: TNF-alpha inhibitors","volume":"3","author":"Tobinick","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.drudis.2008.10.005_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2174\/156720507783018217","article-title":"Perispinal etanercept for treatment of Alzheimer's disease","volume":"4","author":"Tobinick","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.drudis.2008.10.005_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-2094-5-3","article-title":"Perispinal etanercept: potential as an Alzheimer therapeutic","volume":"5","author":"Griffin","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.drudis.2008.10.005_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/oxfordjournals.jbchem.a002969","article-title":"Microglia: activation and their significance in the central nervous system","volume":"130","author":"Nakajima","year":"2001","journal-title":"J. Biochem."},{"key":"10.1016\/j.drudis.2008.10.005_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/13550280290100969","article-title":"Local neuroinflammation and the progression of Alzheimer's disease","volume":"8","author":"McGeer","year":"2002","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.drudis.2008.10.005_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/glia.10146","article-title":"Neuroinflammation in Alzheimer's disease and prion disease","volume":"40","author":"Eikelenboom","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.drudis.2008.10.005_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jnen\/61.7.623","article-title":"The neuropathological and behavioral consequences of intraspinal microglial\/macrophage activation","volume":"61","author":"Popovich","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.drudis.2008.10.005_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.wco.0000169752.54191.97","article-title":"Role of inflammation in neurodegenerative diseases","volume":"18","author":"Minghetti","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.drudis.2008.10.005_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neurobiolaging.2004.05.010","article-title":"Glia and their cytokines in progression of neurodegeneration","volume":"26","author":"Mrak","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.drudis.2008.10.005_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/02646830500382037","article-title":"Clinical aspects of inflammation in Alzheimer's disease","volume":"17","author":"Rosenberg","year":"2005","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.drudis.2008.10.005_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.0953-816x.2001.01666.x","article-title":"Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse","volume":"14","author":"Qiao","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drudis.2008.10.005_bib29","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.2174\/092986707782359981","article-title":"Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease","volume":"14","author":"Shie","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2008.10.005_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF03033906","article-title":"Glial cell dysregulation: a new perspective on Alzheimer disease","volume":"12","author":"von Bernhardi","year":"2007","journal-title":"Neurotox Res."},{"key":"10.1016\/j.drudis.2008.10.005_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature06447","article-title":"Behavioural report of single neuron stimulation in somatosensory cortex","volume":"451","author":"Houweling","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.10.005_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/nature04671","article-title":"Synaptic scaling mediated by glial TNF-alpha","volume":"440","author":"Stellwagen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2008.10.005_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0304-3940(92)90071-E","article-title":"Tumor necrosis factor alters synaptic transmission in rat hippocampal slices","volume":"146","author":"Tancredi","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drudis.2008.10.005_bib34","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1126\/science.1067859","article-title":"Control of synaptic strength by glial TNFalpha","volume":"295","author":"Beattie","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.drudis.2008.10.005_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrn1327","article-title":"Homeostatic plasticity in the developing nervous system","volume":"5","author":"Turrigiano","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2008.10.005_bib36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1185\/030079903125004286","article-title":"Efficacy of etanercept delivered by perispinal administration for chronic back and\/or neck disc-related pain: a study of clinical observations in 143 patients","volume":"20","author":"Tobinick","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.drudis.2008.10.005_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4414\/smw.2003.10163","article-title":"Perispinal TNF-alpha inhibition for discogenic pain","volume":"133","author":"Tobinick","year":"2003","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.drudis.2008.10.005_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-5-2","article-title":"Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration","volume":"5","author":"Tobinick","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.drudis.2008.10.005_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nn1623","article-title":"Astrocyte-mediated control of cerebral blood flow","volume":"9","author":"Takano","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2008.10.005_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nn980","article-title":"Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation","volume":"6","author":"Zonta","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.drudis.2008.10.005_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1196\/annals.1379.004","article-title":"Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease","volume":"1097","author":"Takano","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drudis.2008.10.005_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2353\/ajpath.2007.060708","article-title":"Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging","volume":"170","author":"Csiszar","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drudis.2008.10.005_bib43","article-title":"Microvascular function is impaired in ankylosing spondylitis and improves after TNF{alpha} blockade","author":"van Eijk","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.drudis.2008.10.005_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jns.2008.05.020","article-title":"Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia","volume":"272","author":"Zuliani","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.drudis.2008.10.005_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2377-8-27","article-title":"Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease","volume":"8","author":"Tobinick","year":"2008","journal-title":"BMC Neurol."},{"key":"10.1016\/j.drudis.2008.10.005_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1096\/fasebj.13.1.63","article-title":"TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs","volume":"13","author":"Blasko","year":"1999","journal-title":"FASEB J."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2008.10.005_bib47","first-page":"S1","article-title":"A 24-week randomized, double-blind, placebo-controlled study of the efficacy and tolerability of TNFR: Fc (etanercept) in the treatment of dementia of the Alzheimer type","volume":"23","author":"Bohac","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.drudis.2008.10.005_bib48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00000658-194007000-00016","article-title":"The function of the vertebral veins and their role in the spread of metastases","volume":"112","author":"Batson","year":"1940","journal-title":"Ann. Surg."},{"key":"10.1016\/j.drudis.2008.10.005_bib49","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.BRS.0000128758.64381.75","article-title":"Anatomical and pathological considerations in percutaneous vertebroplasty and kyphoplasty: a reappraisal of the vertebral venous system","volume":"29","author":"Groen","year":"2004","journal-title":"Spine"},{"key":"10.1016\/j.drudis.2008.10.005_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1097-0185(199710)249:2<285::AID-AR16>3.0.CO;2-K","article-title":"Morphology of the human internal vertebral venous plexus: a cadaver study after intravenous Araldite CY 221 injection","volume":"249","author":"Groen","year":"1997","journal-title":"Anat. Rec."},{"key":"10.1016\/j.drudis.2008.10.005_bib51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5694\/j.1326-5377.1947.tb94306.x","article-title":"Revision of the venous system: the role of the vertebral veins","volume":"1","author":"Herlihy","year":"1947","journal-title":"Med. J. Austr."},{"key":"10.1016\/j.drudis.2008.10.005_bib52","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11095-005-6039-0","article-title":"Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route","volume":"22","author":"Johanson","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2008.10.005_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-3806(90)90163-S","article-title":"A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat","volume":"56","author":"Keep","year":"1990","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.drudis.2008.10.005_bib54","first-page":"1","volume":"1","author":"Goldmann","year":"1913","journal-title":"Physikalisch-Mathematische Classe"},{"key":"10.1016\/j.drudis.2008.10.005_bib55","article-title":"Das Sauerstoff-Bedurfnis des Organismus. Eine farbenanalytische Studie [On the oxygen consumption of the body. A study using vital dyes]","author":"Ehrlich","year":"1885","journal-title":"Verlag von August Hirschwald"},{"key":"10.1016\/j.drudis.2008.10.005_bib56","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s00259-007-0451-0","article-title":"PET imaging of acute and chronic inflammation in living mice","volume":"34","author":"Cao","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.drudis.2008.10.005_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2006.11.007","article-title":"What is the blood\u2013brain barrier (not)?","volume":"28","author":"Bechmann","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.drudis.2008.10.005_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1258\/00236770360563750","article-title":"Blood vessels of the rat tail: a histological re-examination with respect to blood vessel puncture methods","volume":"37","author":"Staszyk","year":"2003","journal-title":"Lab. Anim."},{"key":"10.1016\/j.drudis.2008.10.005_bib59","series-title":"ICAD: Molecular Mechanisms of Neurodegeneration; Neurogenesis\/Trophic Factors","article-title":"TNF expressing cells in the subependymal zone of the third ventricle of aged mouse and human brain with Alzheimer's disease pathology","author":"Granic","year":"2008"},{"key":"10.1016\/j.drudis.2008.10.005_bib60","first-page":"221","article-title":"The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines","volume":"111","author":"Chiarini","year":"2006","journal-title":"Ital. J. Anat. Embryol."},{"key":"10.1016\/j.drudis.2008.10.005_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.20180","article-title":"TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels","volume":"26","author":"Laws","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.drudis.2008.10.005_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0197-4580(01)00291-3","article-title":"The role of TNF and its receptors in Alzheimer's disease","volume":"22","author":"Perry","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.drudis.2008.10.005_bib63","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archneur.63.8.1165","article-title":"Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease","volume":"63","author":"Ramos","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.drudis.2008.10.005_bib64","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer's disease","volume":"74","author":"Tarkowski","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.drudis.2008.10.005_bib65","first-page":"25","article-title":"TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study","volume":"8","author":"Tobinick","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.drudis.2008.10.005_bib66","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0149-2918(03)80077-2","article-title":"Targeted etanercept for discogenic neck pain: uncontrolled, open-label results in two adults","volume":"25","author":"Tobinick","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drudis.2008.10.005_bib67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/13854040490507235","article-title":"Verbal fluency patterns in two subgroups of patients with Alzheimer's disease","volume":"18","author":"Fisher","year":"2004","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.drudis.2008.10.005_bib68","first-page":"135","article-title":"Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism","volume":"10","author":"Tobinick","year":"2008","journal-title":"Medscape J. Medicine"},{"key":"10.1016\/j.drudis.2008.10.005_bib69","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/WAD.0b013e31815bf7e1","article-title":"Primary progressive aphasia: a 25-year retrospective","volume":"21","author":"Mesulam","year":"2007","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.drudis.2008.10.005_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1020568013953","article-title":"Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia","volume":"19","author":"Tarkowski","year":"1999","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.drudis.2008.10.005_bib71","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/jnnp.2003.019422","article-title":"Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications","volume":"75","author":"Sjogren","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.drudis.2008.10.005_bib72","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1017\/S1355617705050502","article-title":"Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease","volume":"11","author":"Galasko","year":"2005","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.drudis.2008.10.005_bib73","first-page":"e1","article-title":"Language in Alzheimer's disease","author":"Weiner","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drudis.2008.10.005_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood\u2013brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.drudis.2008.10.005_bib75","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1097\/00007632-200012010-00003","article-title":"2000 Volvo Award winner in basic science studies: exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats","volume":"25","author":"Igarashi","year":"2000","journal-title":"Spine"},{"key":"10.1016\/j.drudis.2008.10.005_bib76","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/00007632-200405150-00006","article-title":"TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord","volume":"29","author":"Ohtori","year":"2004","journal-title":"Spine"},{"key":"10.1016\/j.drudis.2008.10.005_bib77","series-title":"EULAR","article-title":"The efficacy and safety of caudal epidural injection with the TNF-alpha antagonist, etanercept, in patients with disc-herniation-induced sciatica. Results of a randomized, controlled, 1-month follow-up study","author":"Kume","year":"2008"},{"key":"10.1016\/j.drudis.2008.10.005_bib78","unstructured":"Cohen, S., et al. Efficacy of epidural etanercept in the treatment of sciatica. Clinicaltrials.gov ID NCT00364572; results at http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00733096"},{"key":"10.1016\/j.drudis.2008.10.005_bib79","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0149-2918(03)80219-9","article-title":"Targeted etanercept for treatment-refractory pain due to bone metastasis: two case reports","volume":"25","author":"Tobinick","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.drudis.2008.10.005_bib80","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coph.2004.04.004","article-title":"Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer","volume":"4","author":"Anderson","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.drudis.2008.10.005_bib81","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ejca.2006.01.013","article-title":"Therapeutic potential of cytokine and chemokine antagonists in cancer therapy","volume":"42","author":"Yan","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drudis.2008.10.005_bib82","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2008.10.005_bib83","article-title":"Neuropathology of discogenic low back pain: a review","volume":"2","author":"Aoki","year":"2005","journal-title":"Internet J. Spine Surg."},{"key":"10.1016\/j.drudis.2008.10.005_bib84","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/jpet.105.097188","article-title":"Immunomodulatory effects of etanercept in an experimental model of spinal cord injury","volume":"316","author":"Genovese","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2008.10.005_bib85","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/sj.jcbfm.9600487","article-title":"TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice","volume":"27","author":"Bermpohl","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.drudis.2008.10.005_bib86","article-title":"Effects of etanercept and minocycline in a rat model of spinal cord injury","author":"Marchand","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.drudis.2008.10.005_bib87","series-title":"Enbrel\u00ae package insert","author":"Amgen","year":"2008"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644608003735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644608003735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:03:23Z","timestamp":1761221003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644608003735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":87,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1359644608003735"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2008.10.005","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perispinal etanercept for neuroinflammatory disorders","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2008.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}